Home-based medication review in older people: Is it cost effective?

PharmacoEconomics

Volumn 25, Issue 2, 2007, Pages 171-180

  Pacini, Margaret ^a   Smith, Richard D ^a   Wilson, Edward C F ^a   Holland, Richard ^a  

^a UNIVERSITY OF EAST ANGLIA   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AGED; ARTICLE; CLINICAL TRIAL; COMMUNITY HOSPITAL; COST BENEFIT ANALYSIS; DRUG MONITORING; EMERGENCY CARE; HEALTH CARE COST; HOME CARE; HOSPITAL DISCHARGE; HUMAN; MAJOR CLINICAL STUDY; PATIENT COMPLIANCE; PATIENT EDUCATION; PHARMACIST; PRIORITY JOURNAL; PROFESSIONAL PRACTICE; QUALITY ADJUSTED LIFE YEAR; QUESTIONNAIRE;

AGED, 80 AND OVER; COST-BENEFIT ANALYSIS; DRUG THERAPY; HOME CARE SERVICES; HUMANS; PATIENT COMPLIANCE; PATIENT EDUCATION; PHARMACISTS; QUALITY OF LIFE;

EID: 33846612356     PISSN: 11707690     EISSN: None     Source Type: Journal    
DOI: 10.2165/00019053-200725020-00008     Document Type: Article

References (25)

1. Lazarou J, Pomeranz BH, Corey PN. Incidence of adverse drug reactions in hospitalized patients: a meta-analysis of prospective studies. JAMA 1998; 279 (15): 1200-5
2. Department of Health. Implementing medicines-related aspects of the NSF for older people. London: Department of Health, 2001
3. Department of Health. The NHS plan: a plan for investment, a plan for reform. London: Department of Health, 2000
4. Task Force on Medicines Partnership and the national Collaborative Medicines Management Services programme. Room for review: a guide to medication review. The agenda for patients, practitioners and managers. Wallingford: Pharmaceutical Press, 2003
5. Department of Health/PSNC/NHS Confederation. NHS community pharmacy contractual framework advanced service: medicines use review and prescription intervention service. London: Pharmaceutical Services' Negotiating Committee, 2004
6. Lowe CJ, Raynor DK, Purvis J, et al. Effects of a medicine review and education programme for older people in general practice. Br J Clinical Pharmacol 2000; 50 (2): 172-5
7. Begley S, Livingstone C, Hodges N, et al. Impact of domiciliary pharmacy visits on medication management in an elderly population. Int J Pharm Pract 1997; 5: 111-21
8. Lipton HL, Bird JA. The impact of clinical pharmacists' consultations on geriatric patients' compliance and medical care use: a randomised controlled trial. Gerontologist 1994; 34 (3): 307-15
9. Krska J, Cromarty JA, Arriis F, et al. Pharmacist-led medication review in patients over 65: a randomised, controlled trial in primary care. Age Ageing 2001; 30 (3): 205-11
10. Zermansky AG, Petty DR, Raynor DK, et al. Randomised controlled trial of clinical medication review by a pharmacist of elderly patients receiving repeat prescriptions in general practice [comment]. BMJ 2001; 323 (7325): 1340-3
11. Pickard AS, Johnson JA, Farris KB. The impact of pharmacist interventions on health-related quality of life. Ann Pharmacother 1999; 33 (11): 1167-72
12. Holland R, Lenaghan E, Harvey I, et al. Does home based medication review keep older people out of hospital? The HOMER randomised controlled trial. BMJ 2005; 330: 393-5
13. Holland R, Lenaghan E, Harvey I, et al. Delivering a home-based medication review, process measures from the HOMER randomised controlled trial. Int J Pharm Pract 2006; 14: 71-9
14. Rabin R, de Charro F. EQ-5D: a measure of health status from the EuroQol group. Ann Med 2001; 33 (5): 337-43
15. Stewart S, Pearson S, Luke CG, et al. Effects of home-based intervention on unplanned readmissions and out-of-hospital deaths. J Am Geriatr Soc 1998; 46 (2): 174-80
16. Dolan P, Gudex C, Kind P, et al. A social tariff for EuroQoL: results from a UK general population survey. York: University of York, 1995: discussion paper 138
17. Holland R, Smith R, Harvey I, et al. Assessing the quality of life in the elderly: a direct comparison of the EQ-5D and the AQol. Health Econ 2004; 13 (8): 793-805
18. Drummond MF, Sculpher MJ, Torrance GW, et al., editors. Methods for the economic evaluation of health care programmes. 3rd edition. Oxford: Oxford University Press, 2005
19. Rawlins MD, Culyer AJ. National Institute for Clinical Excellence and its value judgments. BMJ 2004; 329: 224-7
20. Netten A, Ress T, Harrison G. Unit costs of health and social care 2000/2001. Canterbury, UK: University of Kent, 2001
21. Department of Health. NHS reference costs 2000. London: Department of Health, 2001
22. Pirmohamed M, James S, Meakin S, et al. Adverse drug reactions as cause of admission to hospital: prospective analysis of 18 820 patients. BMJ 2004; 329 (7456): 15-19
23. Hanlon JT, Weinberger M, Samsa GP, et al. A randomized, controlled trial of a clinical pharmacist intervention to improve inappropriate prescribing in elderly outpatients with polypharmacy. Am J Med 1996; 100 (4): 428-37
24. Mackie CA, Lawson DH, Maclaren AG, et al. A randomised controlled trial of medication review in patients receiving polypharmacy in general practice. Pharm J 1999; Suppl. 263: R7
25. Nazareth I, Burton A, Shulman S, et al. A pharmacy discharge plan for hospitalized elderly patients: a randomized controlled trial. Age Ageing 2001; 30 (1): 33-40